Pediatric Atypical Antipsychotic Outpatient Drug Utilization in the US: Y2002-Y2009

被引：0
|
作者：
Chai, Grace P. [1 ]
Mehta, Hina [1 ]
Governale, Laura [1 ]
机构：
[1] US FDA, Off Surveillance & Epidemiol, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
668
引用
收藏
页码：S282 / S283
页数：2
相关论文
共 43 条
  • [31] Physical compatibility of medications with concentrated neonatal and pediatric parenteral nutrition: A simulated Y-site drug compatibilty study
    Ross, Emma L.
    Petty, Kirsten
    Salinas, Allison
    Her, Cheng
    Carpenter, John F.
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2023, 47 (03) : 372 - 381
  • [32] Effect of US Food and Drug Administration-Approved Pediatric Labeling on Dispensing of Extended-Release Oxycodone in the Outpatient Retail Setting
    Xu, Jing
    Gill, Rajdeep
    Cruz, Marisa
    Staffa, Judy
    Lurie, Peter
    JAMA PEDIATRICS, 2016, 170 (11) : 1103 - 1104
  • [33] Comorbid Conditions and Drug Utilization of Pediatric-Onset Multiple Sclerosis Patients in a Large US Health-Claims Database
    Wenten, Made
    Bloomgren, Gary
    Wang, Jin
    Dilley, Anne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 348 - 349
  • [34] "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-y1) piperazin-1-y1)-2-oxoethyl) acetamides as novel atypical antipsychotic agents" (vol 18, pg 6054, 2008)
    Sekhar, K. V. G. Chandra
    Rao, V. S.
    Devambatla, Ravi Kumar Vyas
    Kumar, M. Murali Krishna
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (09) : 2081 - 2081
  • [35] Iberian Superheroes. National identity, cultural appropriation and US influence in the Spanish comics Iberoes (2009-17), by Inigo Aguirre y Javier Tartaglia
    del Pozo, Jorge Gonzalez
    CELEHIS-REVISTA DEL CENTRO DE LETRAS HISPANOAMERICANAS, 2019, (38): : 132 - 149
  • [36] Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3-b][1,5]benzodiazepine maleate)
    Morimoto, T
    Hashimoto, K
    Yasumatsu, H
    Tanaka, H
    Fujimura, M
    Kuriyama, M
    Kimura, K
    Takehara, S
    Yamagami, K
    NEUROPSYCHOPHARMACOLOGY, 2002, 26 (04) : 456 - 467
  • [37] Neuropharmacological Profile of a Novel Potential Atypical Antipsychotic Drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate)
    Toshihiko Morimoto
    Kenji Hashimoto
    Hiroshi Yasumatsu
    Hiroshi Tanaka
    Masatake Fujimura
    Makoto Kuriyama
    Koreichi Kimura
    Shuzo Takehara
    Keiji Yamagami
    Neuropsychopharmacology, 2002, 26 : 456 - 467
  • [38] Does the increasing placebo response impact outcomes of adult and pediatric ADHD clinical trials? Data from the US Food and Drug Administration 2000-2009
    Khan, Arif
    Mar, Kaysee Fahl
    Brown, Walter A.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 94 : 202 - 207
  • [39] Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12(4-methylpiperazin-1-yl)-6H-[l]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: An in vivo electrophysiological study
    Minabe, Y
    Hashimoto, K
    Shirayama, Y
    Ashby, CR
    SYNAPSE, 2004, 51 (01) : 19 - 26
  • [40] Long Time Scale GPU Dynamics Reveal the Mechanism of Drug Resistance of the Dual Mutant I223R/H275Y Neuraminidase from H1N1-2009 Influenza Virus
    Woods, Christopher J.
    Malaisree, Maturos
    Pattarapongdilok, Naruwan
    Sompornpisut, Pornthep
    Hannongbua, Supot
    Mulholland, Adrian J.
    BIOCHEMISTRY, 2012, 51 (21) : 4364 - 4375
12345